AbbVie Stock Forecast

Stock Price Forecast

According to 31 analysts polled by S&P Global, AbbVie stock has a consensus rating of "Buy" and an average price target of $276.59. The average 1-year stock price forecast is 5.64% higher than the current stock price, while the lowest is $200 (-23.61%) and the highest is $328 (+25.27%).

Price Target: $276.59 (+5.64%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$200	$276.59	$280	$328
Change	-23.61%	+5.64%	+6.94%	+25.27%

Analyst Ratings

The average analyst rating for AbbVie stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	14	16	16	16	16	17
Buy	8	8	8	8	8	8
Hold	9	8	8	6	6	5
Sell	0	0	0	1	1	1
Strong Sell	0	0	0	0	0	0
Total	31	32	32	31	31	31

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Amsellem Piper Sandler	Piper Sandler	Buy Reiterates $298 → $303	Buy	Reiterates	$298 → $303	+15.72%	Aug 20, 2026
Mohit Bansal Wells Fargo	Wells Fargo	Buy Reiterates $295 → $300	Buy	Reiterates	$295 → $300	+14.58%	Aug 17, 2026
Alexandria Hammond Wolfe Research	Wolfe Research	Buy Upgrades $300	Buy	Upgrades	$300	+14.58%	Aug 13, 2026
Emily Field Barclays	Barclays	Buy Reiterates $300	Buy	Reiterates	$300	+14.58%	Aug 12, 2026
Gavin Clark-Gartner Evercore ISI	Evercore ISI	Buy Reiterates $246 → $260	Buy	Reiterates	$246 → $260	-0.70%	Aug 10, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

67.58B

from 61.16B

10.50%

from 61.16B

Revenue Next Year

73.45B

from 67.58B

8.68%

from 67.58B

EPS This Year

14.01

from 10.00

40.09%

from 10.00

EPS Next Year

16.25

from 14.01

15.96%

from 14.01

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	56.20B	58.05B	54.32B	56.33B	61.16B	67.58B
Revenue Growth	22.69%	3.30%	-6.44%	3.71%	8.57%	10.50%
Operating Income	19.76B	20.23B	18.21B	17.42B	21.12B	31.29B
Net Income	11.54B	11.84B	4.86B	4.28B	4.23B	13.86B
EPS	-	-	-	-	10.00	14.01
EPS Growth	-	-	-	-	-1.19%	40.09%
Forward PE	10.04	12.72	13.96	14.81	16.57	18.69
Dividend / Share	5.31	5.71	5.99	6.29	6.65	6.86
Dividend Growth	9.71%	7.53%	4.90%	5.01%	5.72%	3.11%
Free Cash Flow	19.39B	21.26B	22.97B	19.41B	18.34B	24.79B
No. Analysts	-	-	-	-	-	23

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	67.8B
Avg	67.6B
Low	67.1B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	10.8%
Avg	10.5%
Low	9.7%

EPS Forecast

Chart

EPS	2026	2027	2028
High	14.12
Avg	14.01
Low	13.90

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	41.2%
Avg	40.1%
Low	39.0%